Literature DB >> 17303089

Characterization of microvascular basal lamina damage and blood-brain barrier dysfunction following subarachnoid hemorrhage in rats.

Karsten Schöller1, Andreas Trinkl, Mariusz Klopotowski, Serge C Thal, Nikolaus Plesnila, Raimund Trabold, Gerhard F Hamann, Robert Schmid-Elsaesser, Stefan Zausinger.   

Abstract

Vasogenic brain edema is one of the major determinants for mortality following subarachnoid hemorrhage (SAH). Although the formation of vasogenic brain edema occurs on the microvascular level by opening of endothelial tight junctions and disruption of the basal lamina, microvascular changes following experimental SAH are poorly characterized. The aim of the present study was therefore to investigate the time course of blood-brain barrier (BBB) dysfunction and basal lamina damage following SAH as a basis for the better understanding of the pathophysiology of SAH. SAH was induced in Sprague-Dawley rats by an endovascular filament. Animals were sacrificed 6, 24, 48, and 72 h thereafter (n=9 per group). Microvascular basal lamina damage was quantified by collagen type IV immunostaining. Western blotting was used to quantify collagen IV protein content and bovine serum albumin (BSA) extravasation as a measure for basal lamina damage and blood-brain barrier disruption, respectively. BSA Western blot revealed significant (p<0.05) BBB opening in the cerebral cortex ipsilateral to the hemorrhage beginning 6 h and peaking 48 h after SAH. Significant (p<0.05) basal lamina damage occurred with gradual increase from 24 to 72 h. Basal lamina damage correlated significantly with BBB dysfunction (r=-0.63; p=0.0001). Microvascular damage as documented by collagen IV degradation and albumin extravasation is a long lasting and ongoing process following SAH. Due to its delayed manner microvascular damage may be prone for therapeutic interventions. However, further investigations are needed to determine the molecular mechanisms responsible for basal lamina degradation and hence damage of the microvasculature following SAH.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17303089     DOI: 10.1016/j.brainres.2007.01.034

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  39 in total

1.  Basement membrane and stroke.

Authors:  Yao Yao
Journal:  J Cereb Blood Flow Metab       Date:  2018-09-18       Impact factor: 6.200

2.  Irradiation alters MMP-2/TIMP-2 system and collagen type IV degradation in brain.

Authors:  Won Hee Lee; Junie P Warrington; William E Sonntag; Yong Woo Lee
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-04-01       Impact factor: 7.038

Review 3.  Blood-brain barrier permeability imaging as a predictor for delayed cerebral ischaemia following subarachnoid haemorrhage. A narrative review.

Authors:  Michael Amoo; Jack Henry; Niall Pender; Paul Brennan; Matthew Campbell; Mohsen Javadpour
Journal:  Acta Neurochir (Wien)       Date:  2021-01-06       Impact factor: 2.216

Review 4.  Agile delivery of protein therapeutics to CNS.

Authors:  Xiang Yi; Devika S Manickam; Anna Brynskikh; Alexander V Kabanov
Journal:  J Control Release       Date:  2014-06-21       Impact factor: 9.776

Review 5.  Cell-specific blood-brain barrier regulation in health and disease: a focus on hypoxia.

Authors:  S Engelhardt; S Patkar; O O Ogunshola
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

6.  Nanoagonist-mediated endothelial tight junction opening: A strategy for safely increasing brain drug delivery in mice.

Authors:  Xihui Gao; Yuan-Cheng Wang; Yikang Liu; Qi Yue; Zining Liu; Mengjing Ke; Shengyuan Zhao; Cong Li
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

7.  Proteomic identification of novel plasma kallikrein substrates in the astrocyte secretome.

Authors:  Jia Liu; Ben-Bo Gao; Edward P Feener
Journal:  Transl Stroke Res       Date:  2010-08-28       Impact factor: 6.829

8.  Glibenclamide reduces inflammation, vasogenic edema, and caspase-3 activation after subarachnoid hemorrhage.

Authors:  J Marc Simard; Zhihua Geng; S Kyoon Woo; Svetlana Ivanova; Cigdem Tosun; Ludmila Melnichenko; Volodymyr Gerzanich
Journal:  J Cereb Blood Flow Metab       Date:  2008-10-15       Impact factor: 6.200

9.  Anti-Vascular Endothelial Growth Factor Treatment Suppresses Early Brain Injury After Subarachnoid Hemorrhage in Mice.

Authors:  Lei Liu; Masashi Fujimoto; Fumihiro Kawakita; Fumi Nakano; Kyoko Imanaka-Yoshida; Toshimichi Yoshida; Hidenori Suzuki
Journal:  Mol Neurobiol       Date:  2015-08-21       Impact factor: 5.590

Review 10.  Neurological and neurobehavioral assessment of experimental subarachnoid hemorrhage.

Authors:  Hyojin Jeon; Jinglu Ai; Mohamed Sabri; Asma Tariq; Xueyuan Shang; Gang Chen; R Loch Macdonald
Journal:  BMC Neurosci       Date:  2009-08-25       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.